Q7: Who should consider GLP-1 microdosing for MCAS
It currently makes three drugs that contain semaglutide, including: Wegovy, a once-weekly injectable medicine for weight loss and cardiovascular risk reduction Ozempic, a once-weekly injectable medicine for Type 2 diabetes and cardiovascular risk reduction, often prescribed off-label (for a non-FDA-approved use) for weight loss Rybelsus, a daily oral medicine for managing blood sugar levels in people with Type 2 diabetes, and sometimes prescribed off-label for weight loss These three brand-name medicines are the only FDA-approved semaglutide products
Clinical and laboratorial investigation is crucial to determine hyperprolactinemia etiology and to indicate the proper treatment
One of the rare (but potentially underdiagnosed) causes of anion gap metabolic acidosis is acquired 5-oxoprolinuria due to excessive Tylenol ingestion
Severe reactions like the one documented in published case reports can take up to a month to fully resolve, though these are uncommon
[DOI] [PubMed] [Google Scholar] 6.Malmsten M